Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria

Shadi Moghaddas1, Maria S K Stoll, Paul E Minkler

  • 1Department of Medicine, Divisions of Cardiology, Case Western Reserve University, Cleveland, Ohio, USA.

Insights

Aging does not alter cardiolipin content or composition in cardiac mitochondria. This finding suggests that changes in cardiolipin are not responsible for the age-related decline in oxidative phosphorylation in interfibrillar mitochondria.

Area of Science:

  • Mitochondrial biology
  • Aging research
  • Cardiovascular science

Background:

  • Aging selectively impairs oxidative phosphorylation in cardiac interfibrillar mitochondria (IFM), while subsarcolemmal mitochondria (SSM) remain unaffected.
  • Reduced activity of mitochondrial complexes III and IV in aged IFM suggests a potential defect in their lipid environment.
  • Cardiolipin, an oxidatively sensitive phospholipid, is crucial for the maximal activity of complexes III and IV.

Purpose of the Study:

  • To investigate whether aging alters cardiolipin content or composition in cardiac mitochondria.
  • To determine if cardiolipin alterations contribute to the age-related decline in IFM oxidative phosphorylation.

Main Methods:

  • Quantification of mitochondrial phospholipid content and composition in SSM and IFM from adult and aged Fischer 344 rats.
  • Analysis of cardiolipin acyl group and molecular species composition.
  • Assessment of lipid-mediated oxidative modification of complex III subunits.

Main Results:

  • Aging did not change the overall content of mitochondrial phospholipids, including cardiolipin, in either IFM or SSM.
  • The composition of cardiolipin, analyzed by acyl group and molecular species, remained unaltered by aging.
  • No evidence of cardiolipin-derived oxidative damage to complex III was detected.

Conclusions:

  • Alterations in cardiolipin content or composition do not explain the age-related decrease in oxidative phosphorylation in cardiac IFM.
  • The mechanism underlying the aging defect in IFM oxidative phosphorylation in Fischer 344 rats lies elsewhere, not in cardiolipin changes.